Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 928 | 1,122 | 2,995 | 9,247 | 1,802 |
| Receivables | 188 | 84 | 71 | 122 | 304 |
| Inventories | 236 | 241 | 243 | 254 | 210 |
| TOTAL | $3,257 | $4,450 | $6,570 | $12,318 | $5,512 |
| Non-Current Assets | |||||
| PPE Net | 20 | 22 | 24 | 38 | 41 |
| Other Non-Current Assets | 1,977 | 246 | 570 | 891 | 45 |
| TOTAL | $1,997 | $268 | $594 | $929 | $86 |
| Total Assets | $5,254 | $4,718 | $7,164 | $13,248 | $5,597 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,522 | 6,844 | 5,889 | 7,457 | 6,605 |
| TOTAL | $18,720 | $9,829 | $6,536 | $8,468 | $6,623 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7 | 12 | 18 | 23 | 27 |
| TOTAL | $7 | $12 | $18 | $23 | $27 |
| Total Liabilities | $18,727 | $9,841 | $6,554 | $8,491 | $6,650 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,768 | 28,696 | 28,616 | 28,716 | 22,732 |
| Common Shares | 3 | 3 | 3 | 3 | 2 |
| Retained earnings | -103,014 | -94,181 | -88,200 | -83,857 | -78,214 |
| TOTAL | $-13,473 | $-5,123 | $610 | $4,757 | $-1,053 |
| Total Liabilities And Equity | $5,254 | $4,718 | $7,164 | $13,248 | $5,597 |